View Item 

Show simple item record

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy

dc.contributor.authorOliver, B.
dc.contributor.authorHaddow, L.
dc.contributor.authorAgarwal, U.
dc.contributor.authorKumar, M.
dc.contributor.authorEasterbrook, P.
dc.contributor.authorMoosa, M.
dc.contributor.authorSingh, S.
dc.contributor.authorPrice, Patricia
dc.date.accessioned2017-01-30T12:46:43Z
dc.date.available2017-01-30T12:46:43Z
dc.date.created2015-10-29T04:10:06Z
dc.date.issued2013
dc.identifier.citationOliver, B. and Haddow, L. and Agarwal, U. and Kumar, M. and Easterbrook, P. and Moosa, M. and Singh, S. et al. 2013. Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 63 (2).
dc.identifier.urihttp://hdl.handle.net/20.500.11937/25096
dc.identifier.doi10.1097/QAI.0b013e31828e6182
dc.titlePre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
dc.typeJournal Article
dcterms.source.volume63
dcterms.source.number2
dcterms.source.issn1525-4135
dcterms.source.titleJournal of Acquired Immune Deficiency Syndromes
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusOpen access via publisher


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record